Concomitant tacrolimus (TAC) and methotrexate (MTX) pharmacokinetics (PK) in rheumatoid arthritis (RA) patients.

被引：0
|
作者：
Holum, MB [1 ]
Wisemandle, W [1 ]
Bekersky, I [1 ]
机构：
[1] Fujisawa Healthcare Inc, Res & Dev, Deerfield, IL USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
11
引用
收藏
页码：1053 / 1053
页数：1
相关论文
共 50 条
  • [31] IMMUNE CHARACTERIZATION OF CUTANEOUS VASCULITIS DEVELOPED IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) TREATED OR NOT WITH METHOTREXATE (MTX)
    MALAISE, MG
    ANDRE, B
    PAQUET, P
    PIERARD, GE
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S338 - S338
  • [32] The AMBITION study: Superiority of tociluzumab (TCZ) vs methotrexate (MTX) monotherapy in patients with rheumatoid arthritis (RA)
    Jones, G.
    Gu, J. R.
    Lowenstein, M.
    Calvo, A.
    Gomez-Reino, J. J.
    Siri, D.
    Tomsic, M.
    Blackburn, R.
    Woodworth, T.
    Sebba, A.
    Genovese, M.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S618 - S618
  • [33] Development of a New Methotrexate (MTX)-Specific Adherence Tool for Use in the Management of Patients with Rheumatoid Arthritis (RA)
    Curtis, Jeffrey R.
    Aassi, Maher
    Barbosa, Carla Dias
    Bernasconi, Corrado
    Brethous, Michel
    Arnould, Benoit
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 493 - 494
  • [34] SELECTIVE VS UNSELECTIVE LIVER BIOPSIES IN METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS
    ALARCON, GS
    LIGHTFOOT, RW
    KREMER, JM
    WEINBLATT, ME
    WILLKENS, RF
    WILLIAMS, HJ
    FURST, DE
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S64 - S64
  • [35] Genotoxicity assessment using micronuclei assay (MN) in rheumatoid arthritis (RA) patients taking methotrexate (MTX).
    Dorazco-Barragan, G
    Ramos-Remus, C
    Acevez-Avila, FJ
    Alcaraz-Lopez, F
    Fuentez-Ramirez, F
    Michael-Diaz, J
    Torrez-Bugarin, O
    Ventura-Aguilar, A
    Guadalajara, GZ
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S127 - S127
  • [36] PREVENTION OF DEVELOPMENT OF RHEUMATOID ARTHRITIS (RA) IN PATIENTS WITH UNDIFFERENTIATED ARTHRITIS (UA) BY VERY EARLY THERAPEUTIC INTERVENTION OF METHOTREXATE (MTX)
    Kudo-Tanaka, E.
    Matsushita, M.
    Tsuji, S.
    Hirao, M.
    Tsuboi, H.
    Katada, Y.
    Sueishi, M.
    Suenaga, Y.
    Chiba, J.
    Tonai, T.
    Saisho, K.
    Ogata, A.
    Hashimoto, J.
    Ohshima, S.
    Saeki, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 244 - 244
  • [37] Extracellular Microenvironment in Methotrexate (MTX): Treated rheumatoid arthritis patients
    Butur, G.
    Ardeleanu, C.
    Predeteanu, D.
    Manda, G.
    Ursaciuc, C.
    Comanescu, M.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S126 - S126
  • [38] METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SINNETT, MJ
    GROFF, GD
    RADDATZ, DA
    FRANCK, WA
    BERTINO, JS
    [J]. JOURNAL OF RHEUMATOLOGY, 1989, 16 (06) : 745 - 748
  • [39] Pharmacokinetics (PK) of meloxicam oral suspension in juvenile rheumatoid arthritis (JRA) patients compared with adult volunteer and rheumatoid arthritis (RA) patients
    Wood, C. C.
    Kovacs, B.
    Schaefer, H.
    Tillmann, C.
    Espada, G.
    Gedalia, A.
    Staab, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 576 - 576
  • [40] Pharmacokinetics of Oral Methotrexate in Patients With Rheumatoid Arthritis
    Dalrymple, Judith M.
    Stamp, Lisa K.
    O'Donnell, John L.
    Chapman, Peter T.
    Zhang, Mei
    Barclay, Murray L.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3299 - 3308
12345